Table 6.
Outcomes of Respiratory Illness at Enrollment and Follow-up Among Pregnant Women With Acute Respiratory Illness (ARI; Cases), by ARI Classification, and Those Without ARI (Controls)
| Outcome | Cases (n = 80a) | P, AURTI vs ALRTI | Controlsb (n = 91) |
P, Cases vs Controls | |
|---|---|---|---|---|---|
| AURTI (n = 51) |
ALRTI (n = 29) |
||||
| Complications to pregnancy | |||||
| Any | 3 (6) | 2 (7) | >.99 | 4 (4) | .74 |
| Obstetric/gynecologic | 3 | 0 | 1 | ||
| Fetal distress | 0 | 2 | 2 | ||
| Other | 0 | 1 | 1 | ||
| Emergency department visit | |||||
| Any | 1 (2) | 1 (3) | >.99 | 1 (1) | .60 |
| For obstetric/gynecologic reason | 1 | 0 | 0 | ||
| For fetal distress | 0 | 0 | 1 | ||
| Other | 0 | 1 | 0 | ||
| Hospitalization | |||||
| Any | 0 | 1 (3) | .36 | 1 (1) | >.99 |
| For respiratory illness | 0 | 1 | 0 | ||
| For foodborne illness | 0 | 0 | 1 | ||
| Over-the-counter medications | |||||
| Any | 28 (55) | 17 (59) | .75 | 7 (8) | <.01 |
| For cold | 20 | 11 | 4 | ||
| For pain | 12 | 7 | 4 | ||
| Other/vitamins | 1 | 0 | 0 | ||
| Prescription medications | |||||
| Any | 11 (22) | 11 (38) | .12 | 0 | <.01 |
| For cold | 1 | 0 | 0 | ||
| For pain | 1 | 0 | 0 | ||
| Oseltamivir | 1 | 2 | 0 | ||
| Antibiotics | 10 | 9 | 0 | ||
| For asthma | 0 | 3 | 0 | ||
| For gastrointestinal reason | 0 | 1 | 0 | ||
| Reported ARI symptoms at 2 wk follow-up | 11 (23)c | 17 (59) | <.01 | 11 (12)d | <.01 |
Data are no. or no. (%) of participants.
Abbreviations: ALRTI, acute lower respiratory tract illness; AURTI, acute upper respiratory tract illness.
aData are for 80 cases because 1 had fever with malaise without respiratory symptoms.
bIncludes 8 cases who developed AURTI and 3 who developed ALRTI.
cData are for 48 cases with AURTI because 3 were lost to follow-up.
dData are for 89 controls because 2 were lost to follow-up.